Insider Shareholders with Direct Ownership of Lyell Immunopharma, Inc. (LYEL)
This section provides a comprehensive overview of the insiders with direct ownership of Lyell Immunopharma, Inc. (LYEL). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Lyell Immunopharma, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
| 1,685,614 | 0 | 4,685,614 $7.4 Million | 3 |
Sep 08, 2022
Added 3.01%
|
|
|
Lynn Seely
President and CEO |
200,000 | 0 | 200,000 $316,000 | 1 |
Feb 09, 2024
Added 50.0%
|
|
Gary K. Lee
Chief Scientific Officer |
40,000 | 0 | 52,700 $83,266 | 1 |
Feb 09, 2024
Added 43.15%
|
|
Matthew Lang
Chief Business Officer |
50,000 | 0 | 50,000 $79,000 | 1 |
Feb 09, 2024
Added 50.0%
|
|
Stephen J. Hill
Chief Operating Officer |
40,000 | 0 | 48,928 $77,306 | 1 |
Feb 09, 2024
Added 44.98%
|
|
Charles W. Newton
Chief Financial Officer |
40,000 | 0 | 48,729 $76,991 | 1 |
Feb 09, 2024
Added 45.08%
|